In silico evaluation of Philippine Natural Products against SARS-CoV-2 Main Protease.
Ontology highlight
ABSTRACT: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, is a novel strain of coronavirus first reported in December 2019 which rapidly spread throughout the world and was subsequently declared a pandemic by the World Health Organization (WHO) in March 2020. Although vaccines, as well as treatments, have been rapidly developed and deployed, these are still spread thin, especially in the developing world. There is also a continuing threat of the emergence of mutated variants which may not be as responsive to available vaccines and drugs. Accessible and affordable sources of antiviral drugs against SARS-CoV-2 offer wider options for the clinical treatment of populations at risk for severe COVID-19. Using in silico methods, this study identified poten
SUBMITTER: Cheng AJT
PROVIDER: S-EPMC9540280 | biostudies-literature | 2022 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA